#USA #San Diego #Class Action #Securities Fraud #Perrigo Company

Perrigo Company Investors Alert: Action for Those with Losses

Robbins Geller Rudman & Dowd LLP recently announced an opportunity for investors of Perrigo Company plc (NYSE: PRGO) who suffered substantial losses during a defined period to step forward as potential lead plaintiffs in a class action lawsuit against the company. This case, titled French v. Perrigo Company plc, is being pursued in the Southern District of New York and centers around allegations of securities fraud involving significant misstatements regarding Perrigo's financial health and operations.

Background on the Case

The class period extends from February 27, 2023, to November 4, 2025. Investors interested in being appointed as lead plaintiffs have until January 16, 2026, to submit their applications. Many feel that Perrigo and some former executives failed in their disclosure duties under the Securities Exchange Act of 1934, particularly relating to the company’s infant formula business acquired from Nestlé.

In substantial detail, the lawsuit reveals major claims against Perrigo, specifically that the acquired infant formula division was not properly maintained and lacked necessary operational improvements. This underinvestment has resulted in considerable financial fallout for the company, with allegations that Perrigo’s fiscal performance was overstated, misleading investors regarding its profitability.

Investor Losses Explained

In November 2022, Perrigo made headlines with its purchase of Nestlé's Gateway infant formula plant for $170 million, intending to enhance its position in the market. However, according to the lawsuit, this acquisition was fraught with issues, as it was revealed that substantial capital and operational expenditure were required far exceeding initial statements by the company. The lawsuit accuses Perrigo of not disclosing critical manufacturing deficiencies present in the facilities responsible for infant formula production.

Key revelations began to emerge starting February 27, 2024, when Perrigo disclosed concerning acquisition costs estimated between $35 million and $45 million, pushing the stock price down significantly. Reports of a 50% drop in earnings per share highlighted the financial strain—causing stock prices to tumble by over 15% on the news.

As further negative projections unfolded, including a drop in net sales by about 34.5% due to the plant's remediation, the class action lawsuit asserts that Perrigo systematically withheld important information from investors. Subsequent disclosures continued to reveal deteriorating financial conditions, culminating on November 5, 2025, when Perrigo announced a reassessment of its investment in the infant formula business.

The Role of Lead Plaintiffs

In class action lawsuits like this, the Private Securities Litigation Reform Act of 1995 allows investors who acquired Perrigo securities during the applicable timeframe to apply for the role of lead plaintiff. This individual will represent the interests of all class members, potentially capturing a larger share of any future settlements. It's important to note that an investor's eligibility for future recovery does not hinge on their role as lead plaintiff. Instead, any investor from the class period can seek compensation if the lawsuit prevails.

About Robbins Geller

Robbins Geller Rudman & Dowd LLP has a solid track record in advocating for investors affected by securities fraud. The firm has consistently ranked high in securing significant monetary relief for its clients and focuses on class action lawsuits that benefit the wider investor community. With a robust team of legal experts, they represent clients seeking justice against corporate wrongdoing.

The recent situation surrounding Perrigo highlights the importance of investor awareness and the avenues available in addressing alleged corporate misconduct. For more information or to engage in the process, investors are urged to contact Robbins Geller directly or visit their official website.